Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282139 · ClinicalTrials.gov registry record · NA
Aripiprazole in the Treatment of Tourette's Syndrome
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00282139 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 40 participants.
The verdict
NCT00282139, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is an open-label, flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS (or chronic tic disorder) subjects with or without associated OC symptoms and with or without ADHD symptoms.
Interventions
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282139
The ClinicalTrials.gov registry entry for NCT00282139 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole is the first listed.
NCT00282139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00282139 about?
NCT00282139 is a clinical study titled "Aripiprazole in the Treatment of Tourette's Syndrome". This is an open-label, flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS (or chronic tic disorder) subjects with or without associated OC symptoms and with or without ADHD symptoms.
What is the current status of trial NCT00282139?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2004-01. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00282139?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00282139?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.